This Week In HIV Research


This Week in HIV Research: First Case of Alzheimer's Disease in HIV-Positive Individual, and Zinc Deficiency May Contribute to Inflammation

April 29, 2016

This week, a study reports the first diagnosed case of Alzheimer's disease in a person living with HIV, shedding some light on what we thought we knew about dementia and aging with HIV. Meanwhile, another study finds a correlation between zinc deficiency and increased inflammation among people living with HIV. To beat HIV, you have to follow the science!


First Diagnosed Case of Alzheimer's Disease in HIV-Positive Individual Reported

Raymond Scott Turner, M.D., Ph.D.

Raymond Scott Turner, M.D., Ph.D., Director, Georgetown Memory Disorders Program. (Credit: Georgetown University)

Researchers are reporting that a 71-year-old man is the first HIV-positive individual diagnosed with Alzheimer's disease (AD), according to a study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. The case reveals a little more about the complexities of aging with HIV, as we reach a point where more individuals with HIV are growing older.

"This patient may be a sentinel case that disputes what we thought we knew about dementia in HIV-positive individuals," said lead author Raymond Scott Turner, M.D., Ph.D., according to the study press release.

It had been previously thought that HIV-related inflammation would prevent amyloid clumps (brain plaque) from forming and developing Alzheimer's disease.

But now Turner suggests that perhaps those who are aging with HIV and dementia may be misdiagnosed with HIV-associated neurocognitive disorders (HAND), when they're actually developing Alzheimer's disease.

"While it may be challenging to diagnose the cause of dementia in an HIV-positive patient, the diagnosis matters because HAND and AD are treated differently," Turner said, according to the study press release.

"For Alzheimer's disease, we now have four FDA-approved drugs and more effective treatments are on the way. For HAND, we prescribe antiretroviral drugs that have a better chance of penetrating the brain. So getting a correct diagnosis is important, and a critical first step in advancing the field."

Read: This Week in HIV Research: When New Meets Old


Zinc Deficiency May Contribute to Increased Inflammation Among HIV-Positive Individuals

Having a zinc deficiency may be adding to chronic inflammation found in individuals living with HIV, according to a study published in Biological Trace Element Research.

This was the first study to investigate the association between zinc levels in the blood and inflammation among HIV-positive individuals on antiretroviral therapy. Deficiency of zinc, which is an anti-inflammatory agent, is common among people living with HIV, the authors noted in the study press release.

The researchers followed 322 individuals living with HIV and observed an inverse relationship between zinc levels and C-reactive protein levels, a biomarker associated with inflammation. They found that as zinc levels went up, C-reactive protein levels decreased significantly, among men and women in all age groups.

The next steps will be to study whether zinc supplements can help reduce inflammation.

Warren Tong is the senior science editor for and

Follow Warren on Twitter: @WarrenAtTheBody.

Copyright © 2016 Remedy Health Media, LLC. All rights reserved.

Related Stories

This Week in HIV Research: When New Meets Old
This Week in HIV Research: Antibody Being Tested for HIV Prevention, and Differing Results on HCV Treatment in Coinfection
This Week in HIV Research: Determinants of Cognitive Impairment, and Discovery of 'Teenage' Broadly Neutralizing Antibody

This article was provided by TheBodyPRO.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.